These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13868113)

  • 21. [Bronchogenic carcinoma metastazing to the bone with a hyperplastic reticuloplasmocytic reaction of the bone marrow. Contribution to the discussion on the hemoblastic reaction in bone metastases of carcinoma].
    Chyba J; Schreiber B; Opplt J
    Cas Lek Cesk; 1966 Oct; 105(41):1100-6. PubMed ID: 5919878
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in blood proteins in bronchial carcinoma].
    GOMBERT HJ; LOOCK KH
    Dtsch Gesundheitsw; 1953 Mar; 8(11):325-31. PubMed ID: 13067755
    [No Abstract]   [Full Text] [Related]  

  • 23. [Significance of entropy of the blood serum protein fractions in the differential diagnosis of pulmonary tuberculosis and cancer].
    Piatnochka IT; Bugaĭ BG; Piatnochka VI; Chlek MV
    Vrach Delo; 1988 Sep; (9):79-80. PubMed ID: 3213007
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood lactate threshold in patients with bronchogenic carcinoma].
    Miyoshi S; Monden Y; Nakahara K; Ohno K; Fujii Y; Hashimoto J; Kitagawa Y; Kido T; Maeda H; Ikeda M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Jun; 24(6):618-24. PubMed ID: 3773366
    [No Abstract]   [Full Text] [Related]  

  • 25. Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral blood cells of patients with neoplastic diseases. I. Bronchogenic carcinoma.
    Rendeková V; Cerná M; Cerná M; Pechánová E; Pechán I; Krizko J; Virsík K
    Neoplasma; 1983; 30(2):233-8. PubMed ID: 6405288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative behavior of prostaglandin E2 and 13,14-dihydro-15-keto-PGF2 alpha in serum of bronchial carcinoma patients.
    Fiedler L; Zahradnik HP; Schlegel G
    Adv Prostaglandin Thromboxane Res; 1980; 6():585-6. PubMed ID: 7386293
    [No Abstract]   [Full Text] [Related]  

  • 27. Factor VIII inhibitor and bronchogenic carcinoma.
    Al-Ismail SA; Parry DH; Moisey CU; Bloom AL
    Thromb Haemost; 1979 Apr; 41(2):291-5. PubMed ID: 473113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The behavior of trace elements in bronchial carcinoma].
    Dawczynski H; Bartel M; Wagner W
    Z Exp Chir Transplant Kunstliche Organe; 1988; 21(6):344-7. PubMed ID: 3223012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum vitamin 'A' in bronchogenic carcinoma.
    Jain NC; Gupta AP; Saksena HC
    J Assoc Physicians India; 1984 Jun; 32(6):485-6. PubMed ID: 6511722
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
    Samaan NA; Castillo S; Schultz PN; Khalil KG; Johnston DA
    J Clin Endocrinol Metab; 1980 Aug; 51(2):237-41. PubMed ID: 6249833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma.
    Tani P; Kokkola K
    Scand J Respir Dis Suppl; 1972; 80():121-8. PubMed ID: 4510909
    [No Abstract]   [Full Text] [Related]  

  • 33. Bronchogenic carcinoma and hypercalcemia.
    Lueg MC; Barkman HW
    J La State Med Soc; 1985 May; 137(5):66-70. PubMed ID: 4020358
    [No Abstract]   [Full Text] [Related]  

  • 34. [Alpha-subunit of human chorionic gonadotropin in bronchogenic carcinoma].
    Zatloukal P; Glagolicová A; Mĕricka O; Bezdícek P
    Sb Lek; 1993; 94(4):327-31. PubMed ID: 7527586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum hexosamine and its correlations with serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma.
    Kokkola K; Tani P
    Scand J Respir Dis Suppl; 1972; 80():137-41. PubMed ID: 4510910
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum hCG in bronchogenic carcinoma.
    Behera D; Dash S; Malik SK; Dash RJ
    Indian J Chest Dis Allied Sci; 1984; 26(4):238-41. PubMed ID: 6545265
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunohistochemical findings in intrathoracic tumors. I. Comparison of serum and tumor alkaline phosphatase in various types of bronchial carcinoma].
    Eckert H
    Z Erkr Atmungsorgane; 1982; 159(3):267-72. PubMed ID: 7184219
    [No Abstract]   [Full Text] [Related]  

  • 38. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE; DeVald B
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [beta2-Microglobulin and carcino-embryonic antigen in bronchogenic carcinoma (author's transl)].
    Bisset JP; Poirier R; Roux F; Sauvan R; Kleisbauer JP
    Pathol Biol (Paris); 1978 Sep; 26(6):353-4. PubMed ID: 83583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchogenic carcinoma and thromboembolic disease.
    Byrd RB; Divertie MB; Spittell JA
    JAMA; 1967 Dec; 202(11):1019-22. PubMed ID: 6072597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.